Apalutamide and Overall Survival in Prostate Cancer-Reference-Cited by-同舟云学术

Apalutamide and Overall Survival in Prostate Cancer

Published:2021-01 Issue:1 Volume:79 Page:150-158
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Smith Matthew R.,Saad Fred,Chowdhury Simon,Oudard Stéphane,Hadaschik Boris A.,Graff Julie N.,Olmos David,Mainwaring Paul N.,Lee Ji Youl,Uemura Hiroji,De Porre Peter,Smith Andressa A.,Brookman-May Sabine D.,Li Susan,Zhang Ke,Rooney Brendan,Lopez-Gitlitz Angela,Small Eric J.

Funder

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Managing nonmetastatic castration-resistant prostate cancer;Mateo;Eur Urol,2019

2. Androgen signaling in prostate cancer;Dai;Cold Spring Harb Perspect Med,2017

3. An update on androgen deprivation therapy for prostate cancer;Sharifi;Endocr Relat Cancer,2010

4. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches;Karantanos;Oncogene,2013

5. Managing bone metastases and reducing skeletal related events in prostate cancer;Gartrell;Nat Rev Clin Oncol,2014

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial;European Journal of Cancer;2024-11

2. Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real world data of a multicenter study;Journal of Cancer Research and Clinical Oncology;2024-09-09

3. Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis;Prostate Cancer and Prostatic Diseases;2024-09-05

4. Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors;JCO Oncology Practice;2024-09

5. Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer;JAMA Network Open;2024-08-27